Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma

نویسندگان

  • Rikhia Chakraborty
  • Oliver A. Hampton
  • Harshal Abhyankar
  • Daniel J. Zinn
  • Amanda Grimes
  • Brooks Skull
  • Olive Eckstein
  • Nadia Mahmood
  • David A. Wheeler
  • Dolores Lopez-Terrada
  • Tricia L. Peters
  • John M. Hicks
  • Tarek Elghetany
  • Robert Krance
  • Poulikos I. Poulikakos
  • Miriam Merad
  • Kenneth L. McClain
  • Carl E. Allen
  • Donald W. Parsons
چکیده

Juvenile xanthogranuloma (JXG) is a rare histiocytic disorder that is usually benign and self-limiting. We present a case of atypical, aggressive JXG harboring a novel mitogen-activated protein kinase (MAPK) pathway mutation in the MAPK1 gene, which encodes mitogen-activated protein kinase 1 or extracellular signal-regulated 2 (ERK2). Our analysis revealed that the mutation results in constitutive ERK activation that is resistant to BRAF or MEK inhibitors but susceptible to an ERK inhibitor. These data highlight the importance of identifying specific MAPK pathway alterations as part of the diagnostic workup for patients with histiocytic disorders rather than initiating empiric treatment with MEK inhibitors.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Symmetrical giant facial plaque-type juvenile xanthogranuloma persisting beyond 10 years of age.

© 2014 The Authors. doi: 10.2340/00015555-1712 Journal Compilation © 2014 Acta Dermato-Venereologica. ISSN 0001-5555 Juvenile xanthogranuloma (JXG) is a non-Langerhans histiocytosis occurring predominantly in infancy and early childhood. Resolution usually occurs over a period of months to several years, and it is rare for the condition to persist beyond late childhood (1). The symmetrical gian...

متن کامل

Rapid-growing juvenile xanthogranuloma on the nose of a 16-year-old boy

Juvenile xanthogranuloma (JXG) is an uncommon histiocytic cutaneous lesion. It is a type of non-Langerhans cell histiocytosis(WHO Class IIb). The mean age of onset is 2 years of age. The adult form of JXG is relatively rare. The most common affectedarea is the face or the scalp and most of the lesions are less than 5 mm in diameter. This lesion tends to show a self-limited course over several m...

متن کامل

Neonatal Systemic Juvenile Xanthogranuloma with an Ominous Presentation and Successful Treatment

This case report originated from a case of neonatal multisystemic juvenile xanthogranuloma (JXG). The patient presented with blue muffin rush, cervical mass, bone destruction, lung nodule, hepatosplenomegaly, and coagulopathy and was successfully treated with Langerhans cell histiocytosis (LCH) based chemotherapy treatment. Similar cases in literature were reviewed and it seems that JXG, a rela...

متن کامل

Disseminated juvenile xanthogranuloma associated with follicular lymphoma in an adult: successful treatment with chemotherapy and rituximab. A review of the literature.

Juvenile xanthogranuloma is a non-Langerhans cell histiocytosis that typically affects children, but several cases have been reported in adults, some in connection with hematologic malignancies. We present the case of a 61-year-old woman with multiple xanthogranulomas who developed a follicular lymphoma after 4 years of follow-up. After 6 months of treatment with chemotherapy and rituximab, the...

متن کامل

Paratesticular Hamartoma in an Infant

Introduction Solid masses in the testicular and paratesticular region are rare in the pediatric age group more so in infancy. Fibrous hamartoma of infancy (FHI), juvenile xanthogranuloma, capillary hemangioma, desmoid tumor, lipoma of the cord are some of the rare pathologic findings among the benign masses in the paratesticular location. We report a case of paratesticularhamartoma in a 10 mont...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 8  شماره 

صفحات  -

تاریخ انتشار 2017